InVivoMAb anti-human/rat HER2 (neu)
BE0277
ApplicationsFlow Cytometry, ImmunoFluorescence, ImmunoPrecipitation, Other Application
Product group Antibodies
Overview
- SupplierBio X Cell
 - Product NameInVivoMAb anti-human/rat HER2 (neu)
 - Delivery Days Customer7
 - ApplicationsFlow Cytometry, ImmunoFluorescence, ImmunoPrecipitation, Other Application
 - CertificationResearch Use Only
 - ClonalityMonoclonal
 - Clone ID7.16.4
 - Concentration4-11 mg/ml
 - Estimated Purity>95%
 - HostMouse
 - IsotypeIgG2a
 - Storage Instruction2°C to 8°C
 - UNSPSC12352203
 
References
- Sequential Anti-PD1 Therapy Following Dendritic Cell Vaccination Improves Survival in a HER2 Mammary Carcinoma Model and Identifies a Critical Role for CD4 T Cells in Mediating the Response. Kodumudi KN et al., 2019, Front ImmunolRead more
 - Single-cell profiling guided combinatorial immunotherapy for fast-evolving CDK4/6 inhibitor-resistant HER2-positive breast cancer. Wang Q et al., 2019 Aug 23, Nat CommunRead more
 - The therapeutic effect of anti-HER2/neu antibody depends on both innate and adaptive immunity. Park S et al., 2010 Aug 9, Cancer CellRead more
 - Neu antigen-negative variants can be generated after neu-specific antibody therapy in neu transgenic mice. Knutson KL et al., 2004 Feb 1, Cancer ResRead more
 - Shared antigenic epitopes and pathobiological functions of anti-p185(her2/neu) monoclonal antibodies. Zhang H et al., 1999 Sep, Exp Mol PatholRead more
 - Monoclonal antibodies identify a cell-surface antigen associated with an activated cellular oncogene. Drebin JA et al., 1984 Dec 6-12, NatureRead more
 - Inhibition of tumor growth by a monoclonal antibody reactive with an oncogene-encoded tumor antigen. Drebin JA et al., 1986 Dec, Proc Natl Acad Sci U S ARead more